Periostin as a promising target of therapeutical intervention for colorectal cancer

Authors

  • Li Na Song China-Japan Union Hospital of Jilin University, Changchun 130033
  • Ling Xia Li China-Japan Union Hospital of Jilin University, Changchun 130033
  • Qing Hong Shi China-Japan Union Hospital of Jilin University, Changchun 130033
  • Ling Fang China-Japan Union Hospital of Jilin University, Changchun 130033
  • Li Sun China-Japan Union Hospital of Jilin University, Changchun 130033
  • Hai Feng Zhao The First Affiliated Hospital of Jiamusi University, Jiamusi 154003
  • Ning Liu The Second Hospital of Jilin University, Changchun 130021
  • Hong Jun Li China-Japan Union Hospital of Jilin University, Changchun 130033
  • Cheng Yan He China-Japan Union Hospital of Jilin University, Changchun 130033

DOI:

https://doi.org/10.3329/bjp.v9i4.19921

Keywords:

Colorectal cancer, Periostin, siRNA

Abstract

The expression of periostin in the tissue of colorectal cancer patients and its correlation with clinical features were studied. Periostin expression was ~4 fold up-regulated in cancer tissues compared to adjacent non-cancerous tissues. Serum levels of periostin in patients were significantly elevated to 32.6 ± 10.8 ng/mL vs 20.4 ± 11.1 ng/mL in healthy volunteers. Higher preoperative serum periostin levels in patients were closely related to advanced-stage disease (stage III/IV), distant and lymph nodes metastasis. High level of periostin expression was detected in the SW480 human colon carcinoma cells, and could be down-regulated by small interfering RNAs (siRNA). The siRNA-mediated knockdown of periostin arrested the cell cycle at G0/G1 phase and induced apoptotic cell death in the SW480 cells. In conclusion, periostin is a promising prognostic and therapeutic target for colorectal cancer.

Downloads

Download data is not yet available.
Abstract
1508
Download
780 Read
652

References

American Cancer Society. Cancer facts & figures for African Americans, 2013-2014.

Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F, Yuan YZ. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer. Int J Oncol. 2009; 34: 821-28.

Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 26; 383: 1490-502.

Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and disease. Curr Genomics. 2008; 9: 548-55.

Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CT, Kudo A. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 2014; 71: 1279-88.

Dattatreya S. Metastatic colorectal cancer-prolonging overall survival with targeted therapies. South Asian J Cancer. 2013; 2: 179-85.

Herszényi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci. 2010; 14: 249-58.

Hong L, Sun H, Lv X, Yang D, Zhang J, Shi Y. Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep. 2010; 37: 2285-93.

Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999; 14: 1239-49.

Hwang H. Colorectal cancer screening among Asian Americans. Asian Pac J Cancer Prev. 2013; 14: 4025-32.

Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto KI. Periostin in Allergic Inflammation. Allergol Int. 2014; 2014.

Khan M, Zheng B, Yi F, Rasul A, Gu Z, Li T, Gao H, Qazi JI, Yang H, Ma T. Pseudolaric Acid B induces caspase-dependent and caspase-independent apoptosis in u87 glioblastoma cells. 2012; Evid Based Complement Alternat Med. 2012.

Khan M, Qazi JI, Rasul A, Zheng Y, Ma T. Evodiamine induces apoptosis in pancreatic carcinoma PANC-1 cells via NF-?B inhibition. Bangladesh J Pharmacol. 2013; 8: 8-14.

Khoshbaten M, Pishahang P, Nouri M, Lashkari A, Alizadeh M, Rostami-Nejad M. Diagnostic value of fecal calprotectin as a screening biomarker for gastrointestinal malignancies. Asian Pac J Cancer Prev. 2014; 15: 1667-70.

Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T. Periostin: Novel diagnostic and therapeutic target for cancer. Histol Histopathol. 2007; 22: 1167-74.

Lech G, Slotwinski R, Krasnodebski IW. The role of tumor markers and biomarkers in colorectal cancer. Neoplasma 2014; 61: 1-8.

Li B, Wang L, Chi B. Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells. Mol Biol Rep. 2013; 40: 1677-83.

Liu C, Huang SJ, Qin ZL. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells. Chin Med J (Engl). 2010; 123: 3677-83.

Luo JH, Zhou J, Gao Y. Correlation between periostin and SNCG and esophageal cancer invasion, infiltration and apoptosis. Asian Pac J Trop Med. 2013; 6: 516-19.

Norris RA, Moreno-Rodriguez RA, Sugi Y, Hoffman S, Amos J, Hart MM, Potts JD, Goodwin RL, Markwald RR. Periostin regulates atrioventricular valve maturation. Dev Biol. 2008; 316: 200-13.

Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, Fukunaga H, Miyake Y, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, Monden M. Comparative detec-tion of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol. 2002; 20: 4232-41.

Price TJ, Segelov E, Burge M, Haller DG, Ackland SP, Tebbutt NC, Karapetis CS, Pavlakis N, Sobrero AF, Cunningham D, Shapiro JD. Current opinion on optimal treatment for colo-rectal cancer. Expert Rev Anticancer Ther. 2013; 13: 597-611.

Rose J, Augestad KM, Cooper GS. Colorectal cancer surveillance: What's new and what's next. World J Gastroenterol. 2014; 20: 1887-97.

Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci. 2009; 66: 2219-30.

Sorocos K, Kostoulias X, Cullen-McEwen L, Hart AH, Bertram JF, Caruana G Expression patterns and roles of periostin during kidney and ureter development. J Urol. 2011; 186: 1537-44.

Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993; 294: 271-78.

Wu G, Wang X, Zhang X. Clinical implications of periostin in the liver metastasis of colorectal cancer. Cancer Biother Radiopharm. 2013; 2013.

Xiao ZM, Wang XY, Wang AM. Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway. Biotechnol Appl Biochem. 2013; 2013.

Zhu M, Saxton RE, Ramos L, Chang DD, Karlan BY, Gasson JC, Slamon DJ. Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis. Mol Cancer Ther. 2011; 10: 1500-08.

Downloads

Additional Files

Published

2014-10-02

How to Cite

Song, L. N., L. X. Li, Q. H. Shi, L. Fang, L. Sun, H. F. Zhao, N. Liu, H. J. Li, and C. Y. He. “Periostin As a Promising Target of Therapeutical Intervention for Colorectal Cancer”. Bangladesh Journal of Pharmacology, vol. 9, no. 4, Oct. 2014, pp. 488-95, doi:10.3329/bjp.v9i4.19921.

Issue

Vol. 9 No. 4 (2014)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).